002864.SZ
Get informed when a big investor buys or sells
+ FollowUndervalued by 34.1% based on the discounted cash flow analysis.
| Market cap | $2.92 Billion |
|---|---|
| Enterprise Value | $1.77 Billion |
| Dividend Yield | $0.33 (1.64%) |
| Earnings per Share | $0.92 |
| Beta | -0.21 |
| Outstanding Shares | 138,651,728 |
| P/E Ratio | 30.42 |
|---|---|
| PEG | -106.23 |
| Price to Sales | 2.87 |
| Price to Book Ratio | 1.67 |
| Enterprise Value to Revenue | 1.79 |
| Enterprise Value to EBIT | 17.41 |
| Enterprise Value to Net Income | 22 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.03 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd is a pharmaceutical enterprise based in China, comprehensively engaging in the research, development, production, and sale of pharmaceutical products. Furthermore, the company und...